331 related articles for article (PubMed ID: 25240869)
1. Recent developments in tubulin polymerization inhibitors: An overview.
Kaur R; Kaur G; Gill RK; Soni R; Bariwal J
Eur J Med Chem; 2014 Nov; 87():89-124. PubMed ID: 25240869
[TBL] [Abstract][Full Text] [Related]
2. Indole based Tubulin Polymerization Inhibitors: An Update on Recent Developments.
Sunil D; Kamath PR
Mini Rev Med Chem; 2016; 16(18):1470-1499. PubMed ID: 27468786
[TBL] [Abstract][Full Text] [Related]
3. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
Coluccia A; Sabbadin D; Brancale A
Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
[TBL] [Abstract][Full Text] [Related]
4. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.
Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH
Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285
[TBL] [Abstract][Full Text] [Related]
5. Indole based tubulin polymerization inhibitors: An update on recent developments.
Sunil D; Kamath PR
Mini Rev Med Chem; 2016 May; ():. PubMed ID: 27145853
[TBL] [Abstract][Full Text] [Related]
6. Thymoquinone inhibits microtubule polymerization by tubulin binding and causes mitotic arrest following apoptosis in A549 cells.
Acharya BR; Chatterjee A; Ganguli A; Bhattacharya S; Chakrabarti G
Biochimie; 2014 Feb; 97():78-91. PubMed ID: 24113316
[TBL] [Abstract][Full Text] [Related]
7. Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor.
Hsu LC; Durrant DE; Huang CC; Chi NW; Baruchello R; Rondanin R; Rullo C; Marchetti P; Grisolia G; Simoni D; Lee RM
Invest New Drugs; 2012 Aug; 30(4):1379-88. PubMed ID: 21655917
[TBL] [Abstract][Full Text] [Related]
8. Theaflavins depolymerize microtubule network through tubulin binding and cause apoptosis of cervical carcinoma HeLa cells.
Chakrabarty S; Das A; Bhattacharya A; Chakrabarti G
J Agric Food Chem; 2011 Mar; 59(5):2040-8. PubMed ID: 21323312
[TBL] [Abstract][Full Text] [Related]
9. A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization.
Ebenezer O; Shapi M; Tuszynski JA
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409361
[TBL] [Abstract][Full Text] [Related]
10. Selective Inhibition of Spindle Microtubules by a Tubulin-Binding Quinazoline Derivative.
Sawada JI; Ishii H; Matsuno K; Sato M; Suzuki Y; Asai A
Mol Pharmacol; 2019 Nov; 96(5):609-618. PubMed ID: 31471455
[TBL] [Abstract][Full Text] [Related]
11. A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.
Liu W; He M; Li Y; Peng Z; Wang G
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):9-38. PubMed ID: 34894980
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitors of microtubule polymerization- new natural compounds as potential anti-cancer drugs].
Rogalska A; Miśkiewicz K; Marczak A
Postepy Hig Med Dosw (Online); 2015 May; 69():571-85. PubMed ID: 25983296
[TBL] [Abstract][Full Text] [Related]
13. Recent advances of cytotoxic chalconoids targeting tubulin polymerization: Synthesis and biological activity.
Mirzaei H; Emami S
Eur J Med Chem; 2016 Oct; 121():610-639. PubMed ID: 27318983
[TBL] [Abstract][Full Text] [Related]
14. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
Tangutur AD; Kumar D; Krishna KV; Kantevari S
Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
[TBL] [Abstract][Full Text] [Related]
15. [Progress in the study of tubulin inhibitors].
Shang H; Pan L; Yang S; Chen H; Cheng MS
Yao Xue Xue Bao; 2010 Sep; 45(9):1078-88. PubMed ID: 21351562
[TBL] [Abstract][Full Text] [Related]
16. Natural antitubulin agents: importance of 3,4,5-trimethoxyphenyl fragment.
Negi AS; Gautam Y; Alam S; Chanda D; Luqman S; Sarkar J; Khan F; Konwar R
Bioorg Med Chem; 2015 Feb; 23(3):373-89. PubMed ID: 25564377
[TBL] [Abstract][Full Text] [Related]
17. LU103793 (NSC D-669356): a synthetic peptide that interacts with microtubules and inhibits mitosis.
de Arruda M; Cocchiaro CA; Nelson CM; Grinnell CM; Janssen B; Haupt A; Barlozzari T
Cancer Res; 1995 Jul; 55(14):3085-92. PubMed ID: 7606731
[TBL] [Abstract][Full Text] [Related]
18. Novel 2-substituted quinolin-4-yl-benzenesulfonate derivatives: synthesis, antiproliferative activity, and inhibition of cellular tubulin polymerization.
Kakadiya R; Wu YC; Dong H; Kuo HH; Yih LH; Chou TC; Su TL
ChemMedChem; 2011 Jun; 6(6):1119-29. PubMed ID: 21542133
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel class of tubulin inhibitors with promising anticancer activities.
Xi J; Zhu X; Feng Y; Huang N; Luo G; Mao Y; Han X; Tian W; Wang G; Han X; Luo R; Huang Z; An J
Mol Cancer Res; 2013 Aug; 11(8):856-64. PubMed ID: 23666368
[TBL] [Abstract][Full Text] [Related]
20. Tubulin inhibitors: a patent review.
Liu YM; Chen HL; Lee HY; Liou JP
Expert Opin Ther Pat; 2014 Jan; 24(1):69-88. PubMed ID: 24313741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
